This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by McFadden, E. P. Articles by Bertrand, M. E. Search for Related Content PubMed PubMed Citation Articles by McFadden, E. P. Articles by Bertrand, M. E.

Circulation, Vol 86, 187-195, Copyright © 1992 by American Heart Association

ARTICLES

Effect of ketanserin on proximal and distal coronary constrictor responses to intracoronary infusion of serotonin in patients with stable angina, patients with variant angina, and control patients

EP McFadden, C Bauters, JM Lablanche, F Leroy, JG Clarke, M Henry, C Schandrin, GJ Davies, A Maseri and ME Bertrand
Service de Cardiologie B et Hemodynamique, Hopital Cardiologique, Lille, France.

BACKGROUND. Serotonin, released by aggregating platelets, may contribute to or cause myocardial ischemia by constricting epicardial vessels. Experimental studies suggest that this constriction is mediated by two distinct serotonin receptor subtypes: 5- hydroxytryptamine1-like (S1-like) and 5-hydroxytryptamine2 (S2). METHODS AND RESULTS. To determine the relative contribution of S1-like and S2 receptors to the vasoconstrictor effects of serotonin, we studied the effect of ketanserin (0.75 mg, intracoronary), a selective S2 receptor antagonist, on the constrictor response of human coronary vessels to intracoronary infusions of serotonin. In control patients (n = 7), serotonin (10(-4) mol/l) caused significant (p less than 0.05) constriction only in distal segments, which was significantly (p less than 0.05) inhibited by ketanserin. In stable angina patients (n = 8), serotonin (10(-4) mol/l) caused significant constriction in proximal (p less than 0.01) and distal (p less than 0.01) segments, which was significantly inhibited by ketanserin in proximal (p less than 0.05) but not distal (p = 0.30) segments. In patients with variant angina (n = 3), epicardial occlusion at the site of preexisting stenoses in proximal locations occurred at infused concentrations of 10(-6) (one patient) or 10(-5) (two patients) mol/l. The infusion of the same concentration of serotonin after ketanserin again caused epicardial occlusion. CONCLUSIONS. Our results suggest that functionally important S1-like receptors that mediate vasoconstriction exist in the epicardial vessels of patients with stable or variant angina. Their activation, either at hyperreactive sites in patients with variant angina or in the distal epicardial vessels of patients with chronic stable angina, may contribute to or cause myocardial ischemia when serotonin is released after the intracoronary activation of platelets.

This article has been cited by other articles:

				V. Pignay-Demaria, F. Lesperance, R. G. Demaria, N. Frasure-Smith, and L. P. Perrault Depression and anxiety and outcomes of coronary artery bypass surgery Ann. Thorac. Surg., January 1, 2003; 75(1): 314 - 321. [Abstract] [Full Text] [PDF]

				P. Janiak, P. Lainee, Y. Grataloup, C.-E. Luyt, J.-P. Bidouard, J.-B. Michel, S. E O'Connor, and J.-M. Herbert Serotonin receptor blockade improves distal perfusion after lower limb ischemia in the fatty Zucker rat Cardiovasc Res, November 1, 2002; 56(2): 293 - 302. [Abstract] [Full Text] [PDF]

				T. Ishida, S. Kawashima, K.-i. Hirata, T. Sakoda, Y. Shimokawa, Y. Miwa, N. Inoue, T. Ueyama, M. Shiomi, H. Akita, et al. Serotonin-Induced Hypercontraction Through 5-Hydroxytryptamine 1B Receptors in Atherosclerotic Rabbit Coronary Arteries Circulation, March 6, 2001; 103(9): 1289 - 1295. [Abstract] [Full Text] [PDF]

				A. M. VanDenBrink, R. W. M. van den Broek, R. de Vries, A. J. J. C. Bogers, C. J. J. Avezaat, and P. R. Saxena Craniovascular selectivity of eletriptan and sumatriptan in human isolated blood vessels Neurology, November 28, 2000; 55(10): 1524 - 1530. [Abstract] [Full Text] [PDF]

				C. Bauters, C. Amant, A. Boulier, P. Cabrol, E. McFadden, P. Duriez, M. E. Bertrand, and P. Amouyel Paraoxonase Polymorphism (Gln192Arg) as a Determinant of the Response of Human Coronary Arteries to Serotonin Circulation, February 22, 2000; 101(7): 740 - 743. [Abstract] [Full Text] [PDF]

				T. Ishida, K.-i. Hirata, T. Sakoda, S. Kawashima, H. Akita, and M. Yokoyama Identification of mRNA for 5-HT1 and 5-HT2 receptor subtypes in human coronary arteries Cardiovasc Res, January 1, 1999; 41(1): 267 - 274. [Abstract] [Full Text] [PDF]

				A. MaassenVanDenBrink, M. Reekers, W. A. Bax, M. D. Ferrari, and P. R. Saxena Coronary Side-Effect Potential of Current and Prospective Antimigraine Drugs Circulation, July 7, 1998; 98(1): 25 - 30. [Abstract] [Full Text] [PDF]

				T. Kadokami, K. Egashira, K. Kuwata, Y. Fukumoto, T. Kozai, H. Yasutake, T. Kuga, H. Shimokawa, K. Sueishi, and A. Takeshita Altered Serotonin Receptor Subtypes Mediate Coronary Microvascular Hyperreactivityin Pigs With Chronic Inhibitionof Nitric Oxide Synthesis Circulation, July 15, 1996; 94(2): 182 - 189. [Abstract] [Full Text]